The U.S. Food and Drug Administration (FDA) today announced steps it will take to ensure that certain tests used by health care professionals to diagnose and treat patients provide accurate, consistent and reliable results to inform patient care. These steps come at a critical time for genomic, or precision, medicine. As more and more genetic tests are developed and marketed, the public must be able to rely on the accuracy and clinical validity of these tests.
Since 2010, the Genetics/Genomics Competency Center (G2C2) has assembled educational materials for genetic counselors, nurses, pharmacists and physicians assistants. Now, through the efforts of the Inter-Society Coordinating Committee for Practitioner Education in Genomics (ISCC), the G2C2 resource has been expanded to include a new collection of resources for physicians. Read more
Although many doctors are wary about discussing weight loss with their overweight patients - for fear of alienating the patients or being ignored - two recent research studies from a team led by NHGRI's Susan Persky, Ph.D., suggest that doctor-patient talks about the genomic underpinnings of obesity can pay off. Read more
Robert Wildin, M.D., a clinical geneticist with nearly three decades of experience in private and hospital-based medical practice, has joined NHGRI as chief of the Genomic Healthcare Branch (GHB). As GHB chief, Dr. Wildin will provide leadership in promoting the integration of genomic discoveries into clinical and public health practice. Read more
Last Updated: May 8, 2015
Glosario El Hablar De Términos Genéticos
Nuestro glosario de los multimedia con las ilustraciones downloadable.
En Otro Sitio: Centro de Información sobre Enfermedades Genéticas y Raras